| Monograph Title
| Section Head
| Scientific Liaison
|
| ALBENDAZOLE
PF 34(1) Pg. 69 |
Assay |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Title |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Chemical
Info |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Definition |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Packaging
and storage |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
USP
Reference standards <11> |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Identification |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
pH
<791> |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Specific
rotation <781S> |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Water,
Method I <921> |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Residue
on ignition <281> |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Related
compounds |
|
| ALFUZOSIN
HYDROCHLORIDE PF 34(1) Pg. 69 |
Assay |
|
| ALLOPURINOL
PF 34(1) Pg. 70 |
Related
compounds |
|
| ALLOPURINOL
PF 34(1) Pg. 70 |
Limit
of hydrazine |
|
| AMINOPHYLLINE
PF 34(1) Pg. 72 |
Chemical
Info |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Title |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Definition |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Packaging
and storage |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
USP
Reference standards <11> |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Identification |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Uniformity
of dosage units <905> |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Water,
Method I <921> |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Limit
of 4-amino-2-(trifluoromethyl)benzonitrile |
|
| BICALUTAMIDE
TABLETS PF 34(1) Pg. 73 |
Assay |
|
| BUPIVACAINE
HYDROCHLORIDE PF 34(1) Pg. 75 |
Chemical
Info |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Title |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Chemical
Info |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Definition |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Packaging
and storage |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
USP
Reference standards <11> |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Identification |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Specific
rotation <781S> |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Water,
Method I <921> |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Related
compounds |
|
| CABERGOLINE
PF 34(1) Pg. 75 |
Assay |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Title |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Definition |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Packaging
and storage |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
USP
Reference standards <11> |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Identification |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Dissolution
<711> |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Uniformity
of dosage units <905> |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Related
compounds |
|
| CEFDINIR
CAPSULES PF 34(1) Pg. 77 |
Assay |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Title |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Definition |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Packaging
and storage |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Labeling |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
USP
Reference standards <11> |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Identification |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Dissolution
<711> |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Uniformity
of dosage units <905> - For Oral Suspension packaged in single-unit
containers |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Deliverable
volume <698> - For Oral Suspension packaged in multiple-unit containers |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
pH
<791> |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Loss
on drying <731> |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Related
compounds |
|
| CEFDINIR
FOR ORAL SUSPENSION PF 34(1) Pg. 81 |
Assay |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Title |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Chemical
Info |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Definition |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Packaging
and storage |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
USP
Reference standards <11> |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Identification |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Specific
rotation <781S> |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Water,
Method I <921> |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Residue
on ignition <281> |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Heavy
metals, Method II <231> |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Related
compounds |
|
| CEFDINIR
PF 33(6) Pg. 1162 |
Assay |
|
| CHLOROQUINE
PF 34(1) Pg. 86 |
Assay |
|
| DICLOFENAC
POTASSIUM PF 34(1) Pg. 87 |
Identification |
|
| DIDANOSINE
PF 34(1) Pg. 87 |
USP
Reference standards <11> |
|
| DIDANOSINE
PF 34(1) Pg. 87 |
Related
compounds |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Title |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Definition |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Packaging
and storage |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
USP
Reference standards <11> |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Identification |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Bacterial
endotoxins <85> |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
pH
<791> |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Free
diethylstilbestrol |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Diethylstilbestrol
monophosphate |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Other
requirements |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE INJECTION PF 33(6) Pg. 1167 |
Assay |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Title |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Chemical
Info |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Definition |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Packaging
and storage |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
USP
Reference standards <11> |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Identification |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Loss
on drying <731> |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Chloride |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Free
diethylstilbestrol |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Diethylstilbestrol
monophosphate |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Pyridine |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Organic
volatile impurities, Method V <467> |
|
| DIETHYLSTILBESTROL
DIPHOSPHATE PF 33(6) Pg. 1165 |
Assay |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Definition |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Congealing
temperature <651> |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Substances
darkened by potassium hydroxide |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Limit
of dimethyl sulfone |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Limit
of nonvolatile residue |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Related
compounds |
|
| DIMETHYL
SULFOXIDE PF 34(1) Pg. 88 |
Assay |
|
| DIPIVEFRIN
HYDROCHLORIDE PF 34(1) Pg. 89 |
Assay |
|
| DISOPYRAMIDE
PHOSPHATE PF 34(1) Pg. 90 |
Assay |
|
| DRONABINOL
PF 34(1) Pg. 90 |
Packaging
and storage |
|
| DRONABINOL
PF 34(1) Pg. 90 |
Related
compounds |
|
| DRONABINOL
PF 34(1) Pg. 90 |
Assay |
|
| DYCLONINE
HYDROCHLORIDE PF 33(6) Pg. 1167 |
Chemical
Info |
|
| EPINEPHRINE
PF 34(1) Pg. 91 |
Assay |
|
| ESTRADIOL
PF 33(6) Pg. 1167 |
Chemical
Info |
|
| ESTRADIOL
PF 33(6) Pg. 1167 |
Labeling |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
Title |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
Definition |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
Packaging
and storage |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
USP
Reference standards <11> |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
Identification |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
Sterility
<71> |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
pH
<791> |
|
| EUCATROPINE
HYDROCHLORIDE OPHTHALMIC SOLUTION PF 33(6) Pg. 1168 |
Assay |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Title |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Chemical
Info |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Definition |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Packaging
and storage |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Identification |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Melting
range <741> |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Loss
on drying <731> |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Residue
on ignition <281> |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Organic
volatile impurities, Method I <467> |
|
| EUCATROPINE
HYDROCHLORIDE PF 33(6) Pg. 1168 |
Assay |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Title |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Definition |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Packaging
and storage |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
USP
Reference standards <11> |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Identification |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Dissolution
<711> |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Uniformity
of dosage units <905> |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Related
compounds |
|
| FENOFIBRATE
CAPSULES PF 33(6) Pg. 1169 |
Assay |
|
| FENOFIBRATE
CAPSULES PF 34(1) Pg. 91 |
Labeling |
|
| FENOFIBRATE
CAPSULES PF 34(1) Pg. 91 |
Dissolution
<711> |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Title |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Chemical
Info |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Definition |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Packaging
and storage |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
USP
Reference standards <11> |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Identification |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Loss
on drying <731> |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Residue
on ignition <281> |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Heavy
metals, Method II <231> |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Related
compounds |
|
| FLAVOXATE
HYDROCHLORIDE PF 33(6) Pg. 1172 |
Assay |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Title |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Definition |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Packaging
and storage |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
USP
Reference standards <11> |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Identification |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Uniformity
of dosage units <905> |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Related
compounds |
|
| FLAVOXATE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1174 |
Assay |
|
| FLUCONAZOLE
PF 34(1) Pg. 96 |
Related
compounds |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Title |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Chemical
structure |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Chemical
formula |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Molecular
weight |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Chemical
name |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
CAS
number |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Definition |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Packaging
and storage |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
USP
Reference standards |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Identification |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
pH |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Water |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Specific
rotation |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Residue
on ignition |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Heavy
metals |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Residual
solvents |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Related
compounds |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Content
of related compound I |
|
| FORMOTEROL
FUMARATE PF 32(1) Pg. 106 |
Assay |
|
| FORMOTEROL
FUMARATE PF 32(5) Pg. 1450 |
Chemical
Info |
|
| FORMOTEROL
FUMARATE PF 32(5) Pg. 1450 |
Water,
Method I <921> |
|
| FORMOTEROL
FUMARATE PF 32(5) Pg. 1450 |
Related
compounds |
|
| FORMOTEROL
FUMARATE PF 33(3) Pg. 402 |
Definition |
|
| FORMOTEROL
FUMARATE PF 33(3) Pg. 402 |
Labeling |
|
| FORMOTEROL
FUMARATE PF 33(3) Pg. 402 |
USP
Reference standards <11> |
|
| FORMOTEROL
FUMARATE PF 33(3) Pg. 402 |
Content
of related compound I (diastereoisomer) |
|
| FORMOTEROL
FUMARATE PF 33(3) Pg. 402 |
Content
of related compound I (diastereoisomer) |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Title |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Chemical
Info |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Definition |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Packaging
and storage |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
USP
Reference standards <11> |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Identification |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
pH
<791> |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Loss
on drying <731> |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Heavy
metals |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Limit
of foscarnet related compound B, unknown impurities, and total impurities |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Limit
of foscarnet related compound D |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Limit
of phosphate and phosphite |
|
| FOSCARNET
SODIUM PF 34(1) Pg. 97 |
Assay |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Title |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Chemical
Info |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Definition |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Packaging
and storage |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
USP
Reference standards <11> |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Identification |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
pH
<791> |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Loss
on drying <731> |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Residue
on ignition <281> |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Related
compounds |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Assay |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Heavy
Methals, Method II <231> |
|
| GRANISETRON
HYDROCHLORIDE PF 33(6) Pg. 1176 |
Limit
of granisetron related compound E |
|
| IOPAMIDOL
INJECTION PF 33(6) Pg. 1182 |
Assay |
|
| IOPAMIDOL
PF 33(6) Pg. 1179 |
Chemical
Info |
|
| IOPAMIDOL
PF 33(6) Pg. 1179 |
USP
Reference standards <11> |
|
| IOPAMIDOL
PF 33(6) Pg. 1179 |
Identification |
|
| IOPAMIDOL
PF 33(6) Pg. 1179 |
Related
compounds |
|
| ISOPROPYL
ALCOHOL PF 33(6) Pg. 1182 |
USP
Reference standards <11> |
|
| IVERMECTIN
TABLETS PF 33(5) Pg. 918 |
Dissolution
<711> |
|
| LEVALBUTEROL
HYDROCHLORIDE PF 33(1) Pg. 75 |
Color
of a 1% solution <631> |
|
| LEVALBUTEROL
HYDROCHLORIDE PF 33(1) Pg. 75 |
Related
compounds |
|
| LEVALBUTEROL
HYDROCHLORIDE PF 33(1) Pg. 75 |
Residual
solvents |
|
| LEVALBUTEROL
HYDROCHLORIDE PF 33(3) Pg. 416 |
Related
compounds |
|
| LEVALBUTEROL
HYDROCHLORIDE PF 33(3) Pg. 416 |
Residual
solvents |
|
| LEVALBUTEROL
INHALATION SOLUTION PF 33(1) Pg. 79 |
Color
<631> |
|
| LEVALBUTEROL
INHALATION SOLUTION PF 33(1) Pg. 79 |
Related
compounds |
|
| LEVALBUTEROL
INHALATION SOLUTION PF 33(3) Pg. 420 |
Related
compounds |
|
| LEVOTHYROXINE
SODIUM TABLETS PF 34(1) Pg. 100 |
Definition |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Title |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Definition |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Packaging
and storage |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
USP
Reference standards <11> |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Identification |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Dissolution
<711> |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Uniformity
of dosage units <905> |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Related
compounds |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Assay |
|
| LISINOPRIL
AND HYDROCHLOROTHIAZIDE TABLETS PF 33(6) Pg. 1182 |
Dissolution |
|
| MECLIZINE
HYDROCHLORIDE PF 33(6) Pg. 1186 |
Chromatographic
purity |
|
| MECLIZINE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1186 |
Related
compounds |
|
| MECLIZINE
HYDROCHLORIDE TABLETS PF 33(6) Pg. 1186 |
Assay |
|
| MERADIMATE
PF 34(1) Pg. 100 |
Assay |
|
| METHOXSALEN
CAPSULES PF 34(1) Pg. 101 |
Assay |
|
| METHYLPREDNISOLONE
PF 33(6) Pg. 1189 |
Chromatographic
purity |
|
| METHYLPREDNISOLONE
PF 33(6) Pg. 1189 |
Assay |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Title |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Definition |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Packaging
and storage |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
USP
Reference standards <11> |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Identification |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Disintegration
<701> |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Dissolution
<711> |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Uniformity
of dosage units <905> |
|
| MIRTAZAPINE
ORALLY DISINTEGRATING TABLETS PF 33(6) Pg. 1189 |
Assay |
|
| MUPIROCIN
CALCIUM PF 34(1) Pg. 101 |
Identification |
|
| MUPIROCIN
CALCIUM PF 34(1) Pg. 101 |
Related
compounds |
|
| MUPIROCIN
CALCIUM PF 34(1) Pg. 101 |
Assay |
|
| MUPIROCIN
CALCIUM PF 34(1) Pg. 101 |
Assay |
|
| NAPROXEN
DELAYED-RELEASE TABLETS PF 33(6) Pg. 1192 |
Dissolution,
Delayed-Release Dosage Forms, Method B <711> |
|
| NORETHINDRONE
ACETATE AND ETHINYL ESTRADIOL TABLETS PF 33(3) Pg. 432 |
Dissolution
<711> |
|
| NORETHINDRONE
AND ETHINYL ESTRADIOL TABLETS PF 33(6) Pg. 1194 |
Identification |
|
| PEG
3350 AND ELECTROLYTES FOR ORAL SOLUTION PF 33(6) Pg. 1205 |
USP
Reference standards <11> |
|
| PEG
3350 AND ELECTROLYTES FOR ORAL SOLUTION PF 33(6) Pg. 1205 |
Identification |
|
| PEG
3350 AND ELECTROLYTES FOR ORAL SOLUTION PF 33(6) Pg. 1205 |
Assay
for potassium and sodium |
|
| PEG
3350 AND ELECTROLYTES FOR ORAL SOLUTION PF 33(6) Pg. 1205 |
Assay
for polyethylene glycol 3350 |
|
| PENTAZOCINE
HYDROCHLORIDE AND ACETAMINOPHEN TABLETS PF 33(6) Pg. 1200 |
Assay
for pentazocine |
|
| PENTAZOCINE
HYDROCHLORIDE AND ACETAMINOPHEN TABLETS PF 33(6) Pg. 1200 |
Assay
for acetaminophen |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Title |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Chemical
Info |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Definition |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Packaging
and storage |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Labeling |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
USP
Reference standards <11> |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Identification |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Water,
Method I <921> |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Residue
on ignition <281> |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Chromatographic
purity |
|
| PIPERAZINE
ADIPATE PF 33(6) Pg. 1201 |
Assay |
|
| PIPERAZINE
CITRATE PF 34(1) Pg. 106 |
USP
Reference standards <11> |
|
| PIPERAZINE
CITRATE PF 34(1) Pg. 106 |
Identification |
|
| PIPERAZINE
CITRATE PF 34(1) Pg. 106 |
Primary
amines and ammonia |
|
| PIPERAZINE
CITRATE PF 34(1) Pg. 106 |
Chromatographic
purity |
|
| PIPERAZINE
CITRATE PF 34(1) Pg. 106 |
Assay |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Title |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Chemical
Info |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Definition |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Packaging
and storage |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Labeling |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
USP
Reference standards <11> |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Identification |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
pH
<791> |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Water,
Method I <921> |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Residue
on ignition <281> |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Chromatographic
purity |
|
| PIPERAZINE
DIHYDROCHLORIDE PF 33(6) Pg. 1202 |
Assay |
|
| PIPERAZINE
PF 34(1) Pg. 105 |
USP
Reference standards <11> |
|
| PIPERAZINE
PF 34(1) Pg. 105 |
Identification |
|
| PIPERAZINE
PF 34(1) Pg. 105 |
Primary
amines and ammonia |
|
| PIPERAZINE
PF 34(1) Pg. 105 |
Chromatographic
purity |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Title |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Chemical
Info |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Definition |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Packaging
and storage |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Labeling |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
USP
Reference standards <11> |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Identification |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
pH
<791> |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Water,
Method I <921> |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Chromatographic
purity |
|
| PIPERAZINE
PHOSPHATE PF 33(6) Pg. 1204 |
Assay |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Definition |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Packaging
and storage |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Labeling |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
USP
Reference standards <11> |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Identification |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Viscosity
<911> |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Residue
on ignition <281> |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Acid
value |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Water-insoluble
substances |
|
| POLYVINYL
ALCOHOL PF 33(6) Pg. 1206 |
Limit
of methanol (methyl alcohol) and methyl acetate |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
Title |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
Definition |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
Packaging
and storage |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
Labeling |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
USP
Reference standards <11> |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
Beyond-use
date |
|
| POTASSIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 936 |
Assay |
|
| PREDNISOLONE
SODIUM PHOSPHATE PF 34(1) Pg. 108 |
Definition |
|
| PREDNISOLONE
SODIUM PHOSPHATE PF 34(1) Pg. 108 |
Free
prednisolone |
|
| PREDNISOLONE
SODIUM PHOSPHATE PF 34(1) Pg. 108 |
Related
compounds |
|
| PREDNISOLONE
SODIUM PHOSPHATE PF 34(1) Pg. 108 |
Assay |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Title |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Definition |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Packaging
and storage |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Labeling |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
USP
Reference standards <11> |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Identification |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Bacterial
endotoxins <85> |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Sterility
<71> |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
pH
<791> |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Globule
size distribution in lipid injectable emulsions <729> |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Limit
of free fatty acids |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Related
compounds |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Other
requirements |
|
| PROPOFOL
INJECTABLE EMULSION PF 33(6) Pg. 1208 |
Assay |
|
| PROPOXYCAINE
AND PROCAINE HYDROCHLORIDES AND NOREPINEPHRINE BITARTRATE INJECTION PF 34(1)
Pg. 110 |
Assay
for norepinephrine |
|
| PSEUDOEPHEDRINE
HYDROCHLORIDE PF 34(1) Pg. 110 |
Ordinary
impurities <466> |
|
| SALSALATE
TABLETS PF 33(6) Pg. 1211 |
Assay |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Title |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Definition |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Packaging
and storage |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Labeling |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
USP
Reference standards <11> |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Beyond-use
date |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Bacterial
endotoxins <85> |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Sterility
<71> |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Other
requirements |
|
| SODIUM
BROMIDE INJECTION, VETERINARY PF 33(5) Pg. 949 |
Assay |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
Title |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
Definition |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
Packaging
and storage |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
Labeling |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
USP
Reference standards <11> |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
Beyond-use
date |
|
| SODIUM
BROMIDE ORAL SOLUTION, VETERINARY PF 33(5) Pg. 950 |
Assay |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Title |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Chemical
Info |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Definition |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Packaging
and storage |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
USP
Reference standards <11> |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Identification |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Specific
rotation <781S> |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Loss
on drying <731> |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Residue
on ignition <281> |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Heavy
metals, Method II <231> |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Related
substances |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Enantiomeric
purity |
|
| TAMSULOSIN
HYDROCHLORIDE PF 33(6) Pg. 1211 |
Assay |
|
| TORSEMIDE
PF 33(6) Pg. 1213 |
Water,
Method I <921> |
|